BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Profectus BioSciences, Inc. 

1450 South Rolling Road

Baltimore  Maryland  21227  U.S.A.
Phone: 443-543-5011 Fax: 443-543-5013


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
Profectus BioSciences, Inc. Presents Data at Filovirus Medical Countermeasures Meeting Showing That a Single Dose of VSV-Vectored Vaccine Completely Protects Monkey Against Challenge With Ebola and Marburg Viruses 9/24/2013 9:56:41 AM    More...
Profectus BioSciences, Inc. Announces Initiation of Clinical Trial Evaluating its Therapeutic HIV Vaccine in Support of the “Cure Agenda” 9/17/2013 10:06:33 AM    More...
Althea Technologies, Inc. & Profectus BioSciences, Inc. Sign Manufacturing Agreement for Plasmid DNA Production 2/26/2013 9:32:33 AM    More...
Profectus BioSciences, Inc.'s Vesicular Stomatitis Virus-Vectored HIV-1 Vaccine Safe and Immunogenic in Government Sponsored Phase 1 Trial 12/4/2012 10:35:53 AM    More...
Profectus BioSciences, Inc. Receives $5.6M Grant to Develop a Vaccine to Protect Humans against Infection with Nipah/Hendra Viruses 5/9/2012 10:26:42 AM    More...
Profectus BioSciences, Inc. Receives NIAID Grant to Develop a Vesicular Stomatitis Virus-vectored Vaccine for Ebola and Marburg Viruses 5/2/2012 10:15:03 AM    More...
First Human Volunteer Immunized in Clinical Trial of Profectus BioSciences, Inc.’s Vesicular Stomatitis Virus-vectored HIV-1 Vaccine 1/4/2012 7:45:16 AM    More...
Profectus BioSciences, Inc. Receives $5.4M Grant to Develop a Monocolonal Antibody Against Infection by Nipah/Hendra Viruses 12/13/2011 2:02:37 PM    More...
Profectus BioSciences, Inc. Awarded Follow-on Grant from PATH Malaria Vaccine Initiative (MVI) 11/15/2011 9:31:59 AM    More...
Profectus BioSciences, Inc. In-Licenses Portfolio of Patents to Support Vesicular Stomatitis Virus-vectored Vaccine for Ebola and Marburg Viruses 9/21/2011 10:28:14 AM    More...
1234

//-->